Biotech Values

[gofishmarko]

Re : VRTX et al.

Thanks , katie , for your comments on treatment of HIV/HCV coinfected patients.

I recall , maybe incorrectly , that IDIX talked of plans for studies in coinfected patients during an earlier CC. I remember thinking at the time that it might be a strategy to address a patient population that VRTX will not be targeting initially.

The ANDS animal studies are more ominous now that we know the effect was seen in monkeys as well as rats. Did they give any more detail on the nature of the "severe immune response " observed ?

( I haven't had time to listen to any CCs lately , as I'm trying to get ready for a 2-week vacation starting this weekend. A fishing vacation , as you may have guessed.

Also , I was briefly thrown in iHub Jail , for unknown reasons , but managed to bail myself out by tossing my cookies , or else Matt set me free.

None too soon , either. It was scary in there.